CytomX Therapeutics
CTMX
S$3.19
Share price
0.81%
Change (1 day)
82.92%
Change (1 year)
Categories
CytomX Therapeutics (CTMX) - Total debt
Total debt on the balance sheet as of March 2025 : S$10.38 Million
According to CytomX Therapeutics 's latest financial reports the company's total debt is S$10.38 Million. A company’s total debt is the sum of all current and non-current debts.
CytomX Therapeutics - Total debt on balance sheet (from 2014 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | S$12.75 M | -30.88% |
| 2023-12-31 | S$18.45 M | -23.76% |
| 2022-12-31 | S$24.2 M | -17.39% |
| 2021-12-31 | S$29.3 M | -10.94% |
| 2020-12-31 | S$32.9 M | -11.84% |
| 2019-12-31 | S$37.31 M | |
| 2018-12-31 | N/A | |
| 2014-12-31 | S$3.94 M | -25.88% |
| 2013-12-31 | S$5.32 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | S$4.09 M | -60.57% | 🇺🇸 USA |